Mohammad Hamidian1, Johanna J Kenyon1, Kathryn E Holt2, Derek Pickard3, Ruth M Hall4. 1. School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia. 2. Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia. 3. Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK. 4. School of Molecular Bioscience, The University of Sydney, NSW 2006, Australia ruth.hall@sydney.edu.au.
Abstract
OBJECTIVES: To locate the acquired bla(OXA-23) carbapenem resistance gene in an Australian A. baumannii global clone 1 (GC1) isolate. METHODS: The genome of the extensively antibiotic-resistant GC1 isolate A85 harbouring bla(OXA-23) in Tn2006 was sequenced using Illumina HiSeq, and the reads were used to generate a de novo assembly. PCR was used to assemble relevant contigs. Sequences were compared with ones in GenBank. Conjugation experiments were conducted. RESULTS: The sporadic GC1 isolate A85, recovered in 2003, was extensively resistant, exhibiting resistance to imipenem, meropenem and ticarcillin/clavulanate, to cephalosporins and fluoroquinolones and to the older antibiotics gentamicin, kanamycin and neomycin, sulfamethoxazole, trimethoprim and tetracycline. Genes for resistance to older antibiotics are in the chromosome, in an AbaR3 resistance island. A second copy of the ampC gene in Tn6168 confers cephalosporin resistance and the gyrA and parC genes have mutations leading to fluoroquinolone resistance. An 86 335 bp repAci6 plasmid, pA85-3, carrying bla(OXA-23) in Tn2006 in AbaR4, was shown to transfer imipenem, meropenem and ticarcillin/clavulanate resistance into a susceptible recipient. A85 also contains two small cryptic plasmids of 2.7 and 8.7 kb. A85 is sequence type ST126 (Oxford scheme) and carries a novel KL15 capsule locus and the OCL3 outer core locus. CONCLUSIONS: A85 represents a new GC1 lineage identified by the novel capsule locus but retains AbaR3 carrying genes for resistance to older antibiotics. Resistance to imipenem, meropenem and ticarcillin/clavulanate has been introduced into A85 by pA85-3, a repAci6 conjugative plasmid carrying Tn2006 in AbaR4.
OBJECTIVES: To locate the acquired bla(OXA-23) carbapenem resistance gene in an Australian A. baumannii global clone 1 (GC1) isolate. METHODS: The genome of the extensively antibiotic-resistant GC1 isolate A85 harbouring bla(OXA-23) in Tn2006 was sequenced using Illumina HiSeq, and the reads were used to generate a de novo assembly. PCR was used to assemble relevant contigs. Sequences were compared with ones in GenBank. Conjugation experiments were conducted. RESULTS: The sporadic GC1 isolate A85, recovered in 2003, was extensively resistant, exhibiting resistance to imipenem, meropenem and ticarcillin/clavulanate, to cephalosporins and fluoroquinolones and to the older antibiotics gentamicin, kanamycin and neomycin, sulfamethoxazole, trimethoprim and tetracycline. Genes for resistance to older antibiotics are in the chromosome, in an AbaR3 resistance island. A second copy of the ampC gene in Tn6168 confers cephalosporin resistance and the gyrA and parC genes have mutations leading to fluoroquinolone resistance. An 86 335 bp repAci6 plasmid, pA85-3, carrying bla(OXA-23) in Tn2006 in AbaR4, was shown to transfer imipenem, meropenem and ticarcillin/clavulanate resistance into a susceptible recipient. A85 also contains two small cryptic plasmids of 2.7 and 8.7 kb. A85 is sequence type ST126 (Oxford scheme) and carries a novel KL15 capsule locus and the OCL3 outer core locus. CONCLUSIONS: A85 represents a new GC1 lineage identified by the novel capsule locus but retains AbaR3 carrying genes for resistance to older antibiotics. Resistance to imipenem, meropenem and ticarcillin/clavulanate has been introduced into A85 by pA85-3, a repAci6 conjugative plasmid carrying Tn2006 in AbaR4.
Authors: Naomi Runnegar; Hanna Sidjabat; H M Sharon Goh; Graeme R Nimmo; Mark A Schembri; David L Paterson Journal: J Clin Microbiol Date: 2010-08-25 Impact factor: 5.948
Authors: Jubelle K Valenzuela; Lee Thomas; Sally R Partridge; Tanny van der Reijden; Lenie Dijkshoorn; Jon Iredell Journal: J Clin Microbiol Date: 2006-11-15 Impact factor: 5.948
Authors: Mark D Adams; Karrie Goglin; Neil Molyneaux; Kristine M Hujer; Heather Lavender; Jennifer J Jamison; Ian J MacDonald; Kristienna M Martin; Thomas Russo; Anthony A Campagnari; Andrea M Hujer; Robert A Bonomo; Steven R Gill Journal: J Bacteriol Date: 2008-10-17 Impact factor: 3.490
Authors: Kevin J Towner; Benjamin Evans; Laura Villa; Katrina Levi; Ahmed Hamouda; Sebastian G B Amyes; Alessandra Carattoli Journal: Antimicrob Agents Chemother Date: 2011-02-07 Impact factor: 5.191
Authors: Larry A Gallagher; Elizabeth Ramage; Eli J Weiss; Matthew Radey; Hillary S Hayden; Kiara G Held; Holly K Huse; Daniel V Zurawski; Mitchell J Brittnacher; Colin Manoil Journal: J Bacteriol Date: 2015-04-06 Impact factor: 3.490
Authors: Daniel Wibberg; Ileana P Salto; Felix G Eikmeyer; Irena Maus; Anika Winkler; Patrice Nordmann; Alfred Pühler; Laurent Poirel; Andreas Schlüter Journal: Antimicrob Agents Chemother Date: 2018-04-26 Impact factor: 5.191